Vanila Singh

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Melanie Figueroa, Attorney-in-Fact.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vanila Singh:

Company Role Class Num Shares Value Price $ Report Date Ownership
Virpax Pharmaceuticals, Inc. Director Stock Option (right to buy) 25,000 29 Jan 2024 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 22 Mar 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 22 Mar 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $3.66 22 Mar 2022 Direct

Insider Reports Filed by Vanila Singh

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMP NMP Acquisition Corp. 30 Jun 2025 0 $0 3 Director 30 Jun 2025, 21:26
VRPX Virpax Pharmaceuticals, Inc. 29 Jan 2024 1 $0 4 Director 31 Jan 2024, 16:26
VRPX Virpax Pharmaceuticals, Inc. 01 Jan 2023 1 $0 4 Director 04 Jan 2023, 19:30
/report/000110302122000073-singh-vanila-2022-03-22 BIODELIVERY SCIENCES INTERNATIONAL INC 22 Mar 2022 5 $0 4 Director 22 Mar 2022, 17:17
/report/000110302122000024-singh-vanila-2022-01-27 BIODELIVERY SCIENCES INTERNATIONAL INC 27 Jan 2022 4 $0 4 Director 31 Jan 2022, 17:05
VRPX Virpax Pharmaceuticals, Inc. 01 Jan 2022 1 $0 4 Director 05 Jan 2022, 16:29
/report/000110302121000122-singh-vanila-2021-11-22 BIODELIVERY SCIENCES INTERNATIONAL INC 22 Nov 2021 2 $0 4 Director 23 Nov 2021, 16:01
/report/000110302121000084-singh-vanila-2021-08-23 BIODELIVERY SCIENCES INTERNATIONAL INC 23 Aug 2021 4 +$180,480 4 Director 25 Aug 2021, 16:39
/report/000110302121000080-singh-vanila-2021-08-06 BIODELIVERY SCIENCES INTERNATIONAL INC 06 Aug 2021 2 $0 4 Director 10 Aug 2021, 18:26